Literature DB >> 19835916

Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein.

Satoru Ito1, Kazuhiro Nakaso, Keiko Imamura, Takao Takeshima, Kenji Nakashima.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies. alpha-Synuclein is a major component of Lewy bodies. Recently, many studies have focused on the interaction between alpha-synuclein and catecholamine in the pathogenesis of PD. However, no detailed relationship between cathecholamine and alpha-synuclein cytotoxicity has been elucidated. Therefore, this study established PC12 cell lines which overexpress human alpha-synuclein in a tetracycline-inducible manner. The overexpression of human alpha-synuclein increased the number of apoptotic cells in a long-term culture. Moreover, human alpha-synuclein expressing PC12 cells demonstrated an increased vulnerability to several stressors in a short culture period. Thapsigargin increased the SDS soluble oligomers of alpha-synuclein associated with catecholamine-quinone. The unfolded protein response (UPR) study showed that thapsigargin increased eIF2alpha phosphorylation and nuclear GADD153/CHOP induction under alpha-synuclein overexpressed conditions. The activities of the ATF6alpha and IRE1alpha pathways decreased. These findings suggest that an overexpression of alpha-synuclein partly inactivates the UPR. alpha-Methyltyrosine inhibited the dysfunction of the UPR caused by an overexpression of human alpha-synuclein. Therefore, these findings suggest that the coexistence of human alpha-synuclein with catecholamine enhances the endoplasmic reticulum stress-related toxicity in PD pathogenesis. Copyright 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835916     DOI: 10.1016/j.neures.2009.10.005

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  12 in total

1.  Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.

Authors:  Yunden Jinsmaa; Patricia Sullivan; Daniel Gross; Adele Cooney; Yehonatan Sharabi; David S Goldstein
Journal:  Neurosci Lett       Date:  2014-03-23       Impact factor: 3.046

Review 2.  Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Cell Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.046

3.  The structure of dopamine induced alpha-synuclein oligomers.

Authors:  Agata Rekas; Robert B Knott; Anna Sokolova; Kevin J Barnham; Keyla A Perez; Colin L Masters; Simon C Drew; Roberto Cappai; Cyril C Curtain; Chi L L Pham
Journal:  Eur Biophys J       Date:  2010-03-23       Impact factor: 1.733

4.  Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Authors:  David S Goldstein; Patti Sullivan; Adele Cooney; Yunden Jinsmaa; Rachel Sullivan; Daniel J Gross; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2012-10-25       Impact factor: 5.372

5.  Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.

Authors:  Kazuhiro Nakaso; Naoko Tajima; Satoru Ito; Mari Teraoka; Atsushi Yamashita; Yosuke Horikoshi; Daisuke Kikuchi; Shinsuke Mochida; Kenji Nakashima; Tatsuya Matsura
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

6.  ER stress response plays an important role in aggregation of α-synuclein.

Authors:  Peizhou Jiang; Ming Gan; Abdul Shukkur Ebrahim; Wen-Lang Lin; Heather L Melrose; Shu-Hui C Yen
Journal:  Mol Neurodegener       Date:  2010-12-13       Impact factor: 14.195

7.  The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.

Authors:  Su Ling Leong; Mark G Hinds; Andrea R Connor; David P Smith; Eva Illes-Toth; Chi L L Pham; Kevin J Barnham; Roberto Cappai
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

8.  Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells.

Authors:  Mari Teraoka; Kazuhiro Nakaso; Chiaki Kusumoto; Satoshi Katano; Naoko Tajima; Atsushi Yamashita; Teppei Zushi; Satoru Ito; Tatsuya Matsura
Journal:  J Clin Biochem Nutr       Date:  2012-04-06       Impact factor: 3.114

9.  The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding.

Authors:  Chi L L Pham; Roberto Cappai
Journal:  Biosci Rep       Date:  2013-10-22       Impact factor: 3.840

10.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.